Floragraph to present at the Biotech Showcase™ Annual Conference on January 10, 2018

San Jose, January 10, 2008 – Floragraph, Inc., developer of point-of-care microbiome profiling technology, announced today that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.

Alicia Scheffer-Wong, CEO & Co-Founder will present at the Biotech Showcase™ as follows:
Date: Wednesday, January 10, 2018
Time: 10:00AM (PST)
Room: Franciscan - A (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA

Floragraph is developing the first at-home microbiome profiling device. The development of a healthy microbiome over the first year of life is critical to long term health and perturbations to this process can lead to numerous conditions, such as asthma, autoimmune disease, and obesity. Floragraph’s solution provides parents a quantitative measure of their baby’s developing microbiome, enabling early detection and intervention.

“We are very excited to be presenting at Biotech Showcase™,” said Floragraph CEO Alicia Scheffer-Wong. “We look forward to demonstrating our progress thus far and engaging with investors and potential partners. Our unique technology enables parents to be proactive with their newborn’s health and brings the genomics revolution into the home. Our goal is healthier babies and more confident parents.”

Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.

Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Floragraph will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”

About Floragraph:
Floragraph is developing the first point-of-care microbiome profiling device, going from ‘poop to profile’ in 2 hours, at low cost, in your home or doctor's office. The development of a healthy microbiome over the first year of life is critical to long term health and perturbations to this process, including C-sections, antibiotic use, and lack of breastfeeding, can lead to numerous long-term health conditions, such as asthma, autoimmune disease, and obesity. Floragraph’s solution enables longitudinal microbiome profiling at home, in a form factor designed for parents of newborns. Floragraph’s platform will provide new parents a quantitative measure of their baby's developing microbiome, enabling early detection and active prevention. Floragraph is based in the Bay Area and is seeking seed funding.

Floragraph, Inc.
1821 S. Bascom Ave. #207
Campbell, CA 95008
Contact
Alicia Scheffer-Wong, CEO & Co-Founder
(650)704-9590
alicia@floragraph.me
www.floragraph.me